JOANNA FAWZY MORALES, ESQ. CEO, Triage Cancer. Joanna Morales is a cancer rights attorney, author, speaker, and CEO of Triage Cancer, a national, nonprofit organization providing free education on practical and legal issues that may impact individuals coping with cancer and their caregivers, through events, materials, and resources. Morales has spent nearly 30 years working on behalf of individuals with cancer, including five as an Adjunct Professor of Law at Loyola Law School, teaching a seminar in Cancer Rights Law, and eight at the John Wayne Cancer Institute’s Psychosocial Care Program and Positive Appearance Center. She has also taught a Community Advocacy Clinic, as an Adjunct Professor of Law at Wayne State University Law School. Morales co-authored the book, Cancer Rights Law, for the American Bar Association – the first
and only book of its kind. In 2020, she wrote a chapter titled Cancer-Related Legal Issues, for the Oncology Nursing Society’s book, Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum. In 2017, she wrote Preventing or Minimizing Financial Toxicity Across the Continuum of Cancer Care, a chapter for the Oncology Nursing Society’s book, Cancer Survivorship: Transdisciplinary, Patient-Centered Approaches to the Season of Survival. In 2009, she also contributed to a book entitled Work and Cancer Survivors. And, her work has appeared in a variety of other publications. In addition, she has served on numerous cancer community committees and boards: as Chair of the Board of Directors for the California Division of the American Cancer Society, ZERO Prostate Cancer’s Medical Advisory Board, the National Advisory Board of CancerForward, the Stupid Cancer Survivorship Advisory Council, and the Executive Committee of the American Bar Association’s Breast Cancer Task Force. MEREDITH MORGAN, NP, MSN, ACNP-BC Nurse Practitioner, Rogel Cancer Center, University of Michigan. Meredith Morgan is a board-certified acute care nurse practitioner currently working in the Urologic Oncology Clinic at the Rogel Cancer Center in Ann Arbor. She is also an adjunct faculty clinical instructor at the University of Michigan School of Nursing. Morgan leads lectures on prostate cancer for new oncology nurses at the University of Michigan and regularly precepts nurse practitioner students. Her current practice includes prostate cancer survivorship and advanced prostate cancer. She is also active in prostate cancer clinical trials. She has previously worked with prostate cancer patients at Vanderbilt University Medical Center and Weill Cornell Medical College/New York-Presbyterian Hospital. She is a member of the American Urological Association, Oncology Nursing Society, Society of Urologic Nurses and Associates, and the Michigan Council of Nurse Practitioners.
ALICIA MORGANS, MD, MPH Medical Director - Survivorship Program, Dana-Farber Cancer Institute. Dr. Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute in Boston, Massachusetts. She specializes in investigating complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and in investigating and incorporating shared decision making into the treatment process for men with advanced prostate cancer. She also serves as the Principal Investigator for multiple prostate cancer clinical trials, including the ECOG Phase 3 ERADICATE trial. She is a member of the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association,
and is a member of the cardio-oncology committee of American Heart Association. Dr. Morgans’ research focus is on improving care and patient outcomes in advanced prostate cancer. Her research investigates the side effects of cancer treatment (including the prevention, diagnosis of, and treatment of these effects) and treatment decision- making among men with advanced prostate cancer. She also has an interest in supporting clinical research of novel treatments for genitourinary malignancies. Dr. Morgans is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group. She also serves as Vice Chair of ZERO’s Board of Directors. Dr. Morgans has contributed to numerous educational resources on behalf of ZERO.
12 #ZEROSummit2023
Made with FlippingBook flipbook maker